Detalhe da pesquisa
1.
Clinical features, prognostic stratification, and treatment of advanced-stage non-nasal type extranodal natural killer/T-cell lymphoma: a multi-institutional real-world study.
Ann Hematol
; 103(1): 163-174, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37817010
2.
Tislelizumab and radiation therapy in low-risk early-stage extranodal natural killer/T-cell lymphoma, nasal type: a phase II study protocol.
Future Oncol
; 20(5): 245-256, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38018460
3.
Multicenter phase II study of moderate low-dose radiotherapy in indolent non-Hodgkin lymphoma: CLCG-iNHL-01 protocol.
Future Oncol
; 20(2): 71-81, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38179936
4.
Preoperative chemoradiotherapy in older patients with rectal cancer guided by comprehensive geriatric assessment within a multidisciplinary team-a multicenter phase II trial.
BMC Geriatr
; 24(1): 442, 2024 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38773457
5.
Intensive therapy can improve long-term survival in newly diagnosed, advanced-stage extranodal NK/T-cell lymphoma: A multi-institutional, real-world study.
Int J Cancer
; 153(9): 1643-1657, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37539660
6.
The prognostic value of tumour-infiltrating lymphocytes, programmed cell death protein-1 and programmed cell death ligand-1 in Stage I-III triple-negative breast cancer.
Br J Cancer
; 128(11): 2044-2053, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36966236
7.
Evidence of cure for extranodal nasal-type natural killer/T-cell lymphoma with current treatment: an analysis of the CLCG database.
Haematologica
; 108(9): 2467-2475, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36951150
8.
Risk stratification and prognostic value of multi-modal MRI-based radiomics for extranodal nasal-type NK/T-cell lymphoma.
BMC Cancer
; 23(1): 88, 2023 Jan 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36698118
9.
Outcome and risk prediction of early progression in patients with extranodal natural killer/T cell lymphoma from the CLCG study.
Ann Hematol
; 102(9): 2459-2469, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37306711
10.
Treatment and prognosis of newly diagnosed advanced-stage extranodal natural killer / T cell lymphoma: a single-center real-world study across two decades.
Chemotherapy
; 2023 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37984344
11.
ILROG emergency guidelines for radiation therapy of hematological malignancies during the COVID-19 pandemic.
Blood
; 135(21): 1829-1832, 2020 05 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32275740
12.
Preoperative versus postoperative chemo-radiotherapy for locally advanced gastric cancer: a multicenter propensity score-matched analysis.
BMC Cancer
; 22(1): 212, 2022 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35219300
13.
Comparison analysis of first-line asparaginase- versus non-asparaginase-based regimens for early-stage extranodal NK/T-cell lymphoma.
Ann Hematol
; 101(9): 2021-2034, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35798977
14.
Total neoadjuvant therapy for locally advanced gastric cancer and esophagogastric junction adenocarcinoma: study protocol for a prospective, multicenter, single-arm, phase II clinical trial.
BMC Gastroenterol
; 22(1): 359, 2022 Jul 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35902798
15.
POstmastectomy radioThErapy in Node-posiTive breast cancer with or without Internal mAmmary nodaL irradiation (POTENTIAL): a study protocol for a multicenter prospective phase III randomized controlled trial.
BMC Cancer
; 21(1): 1185, 2021 Nov 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34742270
16.
Down-staging depth score could be a survival predictor for locally advanced gastric cancer patients after preoperative chemoradiotherapy.
Chin J Cancer Res
; 33(4): 447-456, 2021 Aug 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34584370
17.
Risk stratification for prediction of locoregional recurrence in patients with pathologic T1-2N0 breast cancer after mastectomy.
BMC Cancer
; 20(1): 1132, 2020 Nov 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33228588
18.
Radiotherapy plays an important role in improving the survival outcome in patients with T1-2N1M0 breast cancer - a joint analysis of 4262 real world cases from two institutions.
BMC Cancer
; 20(1): 1155, 2020 Nov 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33243177
19.
Abnormal pretreatment coagulation factor levels correlate with poor prognosis in patients with early-stage extranodal nasal-type natural/killer T cell lymphoma.
Ann Hematol
; 99(6): 1303-1309, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32333152
20.
Risk-based, response-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: A China Lymphoma Collaborative Group study.
Am J Hematol
; 95(9): 1047-1056, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32449800